HCA医疗保健报告2023年第三季度业绩-动脉网

HCA Healthcare Reports Third Quarter 2023 Results

businesswire 等信源发布 2023-10-24 17:30



可切换为仅中文







NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the third quarter ended September 30, 2023.

田纳西州纳什维尔-（商业线）-HCA Healthcare，Inc。（纽约州：HCA）今天宣布第三季度的财务和运营成果于2023年9月30日结束。

Key third quarter metrics (all percentage changes compare 3Q 2023 to 3Q 2022 unless otherwise noted):

关键的第三季度指标（除非另有说明，所有百分比变化比较3Q 2023至3Q 2022）：

Revenues totaled $16.213 billion

收入总计16213亿美元

Net income attributable to HCA Healthcare, Inc. totaled $1.079 billion, or $3.91 per diluted share

HCA Healthcare，Inc。的净收入总计10.79亿美元，即每个稀释份额3.91美元

Adjusted EBITDA totaled $2.880 billion

调整后的EBITDA总计28.8亿美元

Cash flows from operating activities totaled $2.479 billion

经营活动现金流量总计24.79亿美元

Same facility admissions increased 3.4 percent while same facility equivalent admissions increased 4.1 percent

同一设施招生人数增加3.4%，同一设施同等招生人数增加4.1%

“During the quarter, most aspects of our business were positive, including continued solid demand for our services, which translated into strong revenue growth. However, our results were unfavorably impacted by our Valesco physician staffing joint venture, which performed below our expectations,” said Sam Hazen, Chief Executive Officer of HCA Healthcare.

“在本季度，我们业务的大部分方面都是积极的，包括对我们服务的持续强劲需求，这转化为强劲的收入增长。然而，我们的结果受到Valesco physician人员配备合资企业的不利影响，这超出了我们的预期，”HCA Healthcare首席执行官Sam Hazen说。

“I am proud of our people for what they do every day, and I want to thank them for their dedication to delivering on our purpose.”.

“我为我们的人民每天所做的事情感到骄傲，我要感谢他们为实现我们的目标而奉献的精神。”。

Revenues in the third quarter of 2023 totaled $16.213 billion, compared to $14.971 billion in the third quarter of 2022. Net income attributable to HCA Healthcare, Inc. totaled $1.079 billion, or $3.91 per diluted share, compared to $1.134 billion, or $3.91 per diluted share, in the third quarter of 2022..

2023年第三季度的收入总额为16213亿美元，而2022年第三季度的收入为14971亿美元。归因于HCA Healthcare，Inc。的净收入总计10.79亿美元，即每个稀释股3.91美元，而2022年第三季度则为11.34亿美元，即每个稀释股3.91美元。。

For the third quarter of 2023, Adjusted EBITDA totaled $2.880 billion, compared to $2.902 billion in the third quarter of 2022. Adjusted EBITDA is a non-GAAP financial measure. A table providing supplemental information on Adjusted EBITDA and reconciling net income attributable to HCA Healthcare, Inc.

2023年第三季度，调整后的EBITDA总计28.8亿美元，而2022年第三季度为29.02亿美元。调整后的EBITDA是非GAAP财务指标。提供有关调整后的EBITDA的补充信息并协调可归因于HCA Healthcare，Inc。的净收入的表格。

to Adjusted EBITDA is included in this release..

调整后的EBITDA包含在此版本中。。

The third quarter of 2023 includes revenues of $397 million and other operating expenses of $195 million related to the Florida directed payment program year that ended September 30, 2023.

2023年第三季度包括截至2023年9月30日的佛罗里达定向支付计划年度的3.97亿美元收入和1.95亿美元的其他运营费用。

Same facility admissions increased 3.4 percent while same facility equivalent admissions increased 4.1 percent in the third quarter of 2023, compared to the prior year period. Same facility emergency room visits increased 3.5 percent in the third quarter of 2023, compared to the prior year period. Same facility inpatient surgeries increased 1.6 percent, and same facility outpatient surgeries increased 0.9 percent in the third quarter of 2023, compared to the same period of 2022.

与去年相比，2023年第三季度同一设施的入院率增加了3.4%，而同一设施的入院率增加了4.1%。与去年相比，2023年第三季度同一设施急诊室就诊人数增加了3.5%。与2022年同期相比，2023年第三季度同一设施住院手术增加了1.6%，同一设施门诊手术增加了0.9%。

Same facility revenue per equivalent admission increased 3.6 percent in the third quarter of 2023, compared to the third quarter of 2022..

与2022年第三季度相比，2023年第三季度每等值入场的同一设施收入增加了3.6%。。

Nine Months Ended September 30, 2023

九个月截至2023年9月30日

Revenues for the nine months ended September 30, 2023 totaled $47.665 billion, compared to $44.736 billion in the same period of 2022. Net income attributable to HCA Healthcare, Inc. was $3.635 billion, or $13.07 per diluted share, for the nine months ended September 30, 2023 compared to $3.562 billion, or $11.97 per diluted share, for the first nine months of 2022.

9个月的收入截至2023年9月30日，总计476.65亿美元，而2022年同期为447.36亿美元。在2023年9月30日结束的9个月中，HCA Healthcare，Inc。的净收入为36.35亿美元，即每个稀释股13.07美元，而2022年前9个月则为35.62亿美元，即每个稀释股11.97美元。

Results for the nine months ended September 30, 2023 include losses on sales of facilities of $12 million, or $0.07 per diluted share. Results for the nine months ended September 30, 2022 include losses on sales of facilities of $25 million, or $0.09 per diluted share, and losses on retirement of debt of $78 million, or $0.20 per diluted share..

截至2023年9月30日的9个月的结果包括销售设施损失1200万美元，或每个稀释份额0.07美元。截至2022年9月30日的9个月的结果包括设施销售损失2500万美元，即每个稀释股0.09美元，债务退休损失7800万美元，或每个稀释股0.20美元。。

Balance Sheet and Cash Flows from Operations

资产负债表和经营现金流量

As of September 30, 2023, HCA Healthcare, Inc.’s balance sheet reflected cash and cash equivalents of $891 million, total debt of $39.346 billion, and total assets of $54.589 billion. During the third quarter of 2023, capital expenditures totaled $1.147 billion, excluding acquisitions. Cash flows provided by operating activities in the third quarter of 2023 totaled $2.479 billion, compared to $3.020 billion in the third quarter of 2022..

截至2023年9月30日，HCA Healthcare，Inc。的资产负债表反映现金和现金当量为8.91亿美元，债务总额为393.46亿美元，总资产为545.89亿美元。在2023年第三季度，资本支出总额为11.47亿美元，不包括收购。2023年第三季度经营活动提供的现金流量总计24.79亿美元，而2022年第三季度为30.2亿美元。。

During the third quarter of 2023, the Company repurchased 4.2 million shares of its common stock at a cost of $1.140 billion. The Company had $1.685 billion remaining under its repurchase authorization as of September 30, 2023. As of September 30, 2023, the Company had $6.455 billion of availability under its credit facilities..

在2023年第三季度，该公司以11.4亿美元的成本重新购买了420万股普通股。截至2023年9月30日，该公司仍有16.85亿美元的赎回授权。截至2023年9月30日，该公司在其信用设施下的可用性为64.55亿美元。。

Dividend

股息

HCA today announced that its Board of Directors declared a quarterly cash dividend of $0.60 per share on the Company’s common stock. The dividend will be paid on December 28, 2023 to stockholders of record at the close of business on December 14, 2023.

HCA今天宣布，其董事会宣布本公司普通股的季度现金股息为0.60美元。股息将于2023年12月28日支付给2023年12月14日业务结束时的有记录股东。

The declaration and payment of any future dividend will be subject to the discretion of the Board of Directors and will depend on a variety of factors, including the Company’s financial condition and results of operations and contractual restrictions. Future dividends are expected to be funded by cash balances and future cash flows from operations..

任何未来股息的宣布和支付将由董事会自行决定，并取决于各种因素，包括公司的财务状况和运营结果以及合同限制。未来的股息预计将由现金余额和未来运营现金流量资助。。

2023 Revised Guidance

2023修订指南

The 2023 guidance ranges for the year have been revised from our second quarter release as follows:

本年度的2023年指导范围已从第二季度版本修订如下：

Previous 2023 Guidance Range

以前的2023指导范围

as of July 27, 2023

截至2023年7月27日

2023 Guidance Range

2023指导范围

as of October 24, 2023

截至2023年10月24日

Revenues

收入

$63.25 to $64.75 billion

63.25美元至647.5亿美元

$63.5 to $64.5 billion

63.5美元至645亿美元

Net Income Attributable to HCA Healthcare, Inc.

HCA医疗保健公司的净收入。

$4.900 to $5.255 billion

4.900美元至52.55亿美元

$4.940 to $5.130 billion

4.940美元至51.3亿美元

Adjusted EBITDA

调整后的EBITDA

$12.3 to $12.8 billion

12.3美元至128亿美元

$12.3 to $12.6 billion

12.3美元至126亿美元

EPS (diluted)

EPS（稀释）

$17.70 to $18.90 per diluted share

每个稀释股$17.70至$18.90

$17.80 to $18.50 per diluted share

每个稀释股$17.80至$18.50

The Company’s 2023 guidance contains a number of assumptions, including, among others, the Company’s current expectations regarding the impact of the COVID-19 pandemic, patient volumes and payor mix as well as general economic conditions, including inflation, and excludes the impact of items such as, but not limited to, gains or losses on sales of facilities, losses on retirement of debt, legal claims costs and impairment of long-lived assets..

该公司的2023指南包含许多假设，其中包括公司目前对COVID-19大流行的影响，患者数量和付款人组合以及包括通货膨胀在内的一般经济状况的预期，并排除项目的影响例如但不限于设施销售的收益或损失，债务退休损失，法律索赔成本与长寿资产减值。。

Adjusted EBITDA is a non-GAAP financial measure. A table reconciling forecasted net income attributable to HCA Healthcare, Inc. to forecasted Adjusted EBITDA is included in this release.

调整后的EBITDA是非GAAP财务指标。本版本包含一个表格，将HCA Healthcare，Inc。的预测净收入与预测的调整后EBITDA进行核对。

The Company’s guidance is based on current plans and expectations and is subject to a number of known and unknown uncertainties and risks, including those set forth below in the Company’s “Forward-Looking Statements.”

本公司的指导基于当前的计划和期望，并受到许多已知和未知的不确定性和风险的影响，包括本公司“前瞻性声明”中列出的那些不确定性和风险

Earnings Conference Call

收入电话会议

HCA Healthcare will host a conference call for investors at 9:00 a.m. Central Daylight Time today. All interested investors are invited to access a live audio broadcast of the call via webcast. The broadcast also will be available on a replay basis beginning this afternoon. The webcast can be accessed through the Company’s Investor Relations web page at https://investor.hcahealthcare.com/events-and-presentations/default.aspx..

HCA Healthcare将于今天中午9:00召开投资者电话会议。所有感兴趣的投资者都被邀请通过网络广播访问通话的实时音频广播。从今天下午开始，广播也将重播。网络广播可以通过公司的投资者关系网页访问https://investor.hcahealthcare.com/events-and-presentations/default.aspx..

About the Company

关于公司

As of September 30, 2023, HCA operated 183 hospitals and approximately 2,300 ambulatory sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics, in 20 states and the United Kingdom.

截至2023年9月30日，HCA在20个州和英国运营了183家医院和大约2300个门诊护理点，包括手术中心，独立急诊室，紧急护理中心和医生诊所。

Forward-Looking Statements

前瞻性声明

This press release contains forward-looking statements within the meaning of the federal securities laws, which involve risks and uncertainties. Forward-looking statements include the Company’s financial guidance for the year ending December 31, 2023, as well as other statements that do not relate solely to historical or current facts.

本新闻稿包含联邦证券法含义内的前瞻性声明，涉及风险和不确定性。前瞻性陈述包括本公司截至2023年12月31日的财务指导，以及其他仅与历史或当前事实无关的陈述。

Forward-looking statements can be identified by the use of words like “may,” “believe,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “initiative” or “continue.” These forward-looking statements are based on our current plans and expectations and are subject to a number of known and unknown uncertainties and risks, many of which are beyond our control, which could significantly affect current plans and expectations and our future financial position and results of operations.

前瞻性陈述可以通过使用诸如“可能”，“相信”，“将会”，“期望”，“项目”，“估计”，“预期”，“计划”，“主动性”或“继续”之类的词语来识别。这些前瞻性陈述基于我们当前的计划和期望，并受到许多已知和未知的不确定性和风险的影响，其中许多是我们无法控制的，这可能会严重影响当前的计划和期望以及我们未来的财务状况和运营结果。

These factors include, but are not limited to, (1) changes in or related to general economic conditions nationally and regionally in our markets, including inflation and economic and business conditions (and the impact thereof on the economy, financial markets and banking industry); changes in revenues due to declining patient volumes; changes in payer mix (including increases in uninsured and underinsured patients); potential increased expenses related to labor, supply chain or other expenditures; workforce disruptions; supply shortages and disruptions; and the impact of potential federal government shutdowns, (2) the impact of our substantial indebtedness and the ability to refinance such indebtedness on acceptable terms, (3) the impact of current and future federal and state health reform initiatives and possible changes to other federal, state or local laws and regulations affecting the health care industry, including, but not limited to, the Pati.

这些因素包括但不限于：（1）我们市场国内和地区一般经济状况的变化或与之相关，包括通货膨胀和经济及商业状况（及其对经济，金融市场和银行业的影响））；由于患者数量下降导致收入变化；付款人组合的变化（包括未投保和未投保患者的增加）；与劳动力，供应链或其他支出有关的潜在增加费用；劳动力中断；供应短缺和中断；以及潜在的联邦政府停工的影响，（2）我们的重大负债的影响以及以可接受的条件再融资此类负债的能力，（3）当前和未来联邦和州医疗改革计划的影响以及其他可能的变化影响医疗保健行业的联邦，州或地方法律法规，包括但不限于，Pati。

HCA Healthcare, Inc.

HCA医疗保健股份有限公司。

Condensed Consolidated Comprehensive Income Statements

简明综合综合收入报表

Third Quarter

第三季度

Unaudited

未经审计

(Dollars in millions, except per share amounts)

（百万美元，不包括每股金额）

2023

2022

Amount

数量

Ratio

比率

Amount

数量

Ratio

比率

Revenues

收入

$16,213

100.0

$14,971

100.0

Salaries and benefits

薪资与福利

7,556

46.6

6,899

46.1

Supplies

用品

2,417

14.9

2,320

15.5

Other operating expenses

其他运营费用

3,379

20.8

2,860

19.1

Equity in earnings of affiliates

分支机构收益权益

(19

)

(0.1

)

(10

)

(0.1

)

Depreciation and amortization

折旧和摊销

769

4.7

749

5.0

Interest expense

利息费用

483

3.0

446

3.0

Losses (gains) on sales of facilities

设施销售损失（收益）

)

14,583

89.9

13,267

88.6

Income before income taxes

所得税前的收入

1,630

10.1

1,704

11.4

Provision for income taxes

所得税的规定

355

2.2

360

2.4

Net income

净收入

1,275

7.9

1,344

9.0

Net income attributable to noncontrolling interests

归因于非控制利益的净收入

196

1.2

210

1.4

Net income attributable to HCA Healthcare, Inc.

HCA医疗保健公司的净收入。

$1,079

6.7

$1,134

7.6

Diluted earnings per share

稀释的股份收益

$3.91

Shares used in computing diluted earnings per share (millions)

用于计算稀释的人均收益（百万）的股份

275.424

289.852

Comprehensive income attributable to HCA Healthcare, Inc.

HCA医疗保健公司的综合收入。

$1,044

$1,057

HCA Healthcare, Inc.

HCA医疗保健股份有限公司。

Condensed Consolidated Comprehensive Income Statements

简明综合综合收入报表

For the Nine Months Ended September 30, 2023 and 2022

截至2023年9月30日及2022年9月30日的9个月

Unaudited

未经审计

(Dollars in millions, except per share amounts)

（百万美元，不包括每股金额）

2023

2022

Amount

数量

Ratio

比率

Amount

数量

Ratio

比率

Revenues

收入

$47,665

100.0

$44,736

100.0

Salaries and benefits

薪资与福利

21,917

46.0

20,630

46.1

Supplies

7,318

15.4

6,942

15.5

Other operating expenses

其他运营费用

9,316

19.5

8,305

18.6

Equity in losses (earnings) of affiliates

关联公司损失权益（收益）

(29

)

(0.1

)

Depreciation and amortization

折旧和摊销

2,288

4.9

2,219

4.9

Interest expense

利息费用

1,447

3.0

1,288

2.9

Losses on sales of facilities

设施销售损失

0.1

Losses on retirement of debt

债务退休损失

0.2

42,304

88.8

39,458

88.2

Income before income taxes

所得税前的收入

5,361

11.2

5,278

11.8

Provision for income taxes

所得税的规定

1,131

2.3

1,090

2.4

Net income

净收入

4,230

8.9

4,188

9.4

Net income attributable to noncontrolling interests

归因于非控制利益的净收入

595

1.3

626

1.4

Net income attributable to HCA Healthcare, Inc.

HCA医疗保健公司的净收入。

$3,635

7.6

$3,562

8.0

Diluted earnings per share

稀释的股份收益

$13.07

$11.97

Shares used in computing diluted earnings per share (millions)

用于计算稀释的人均收益（百万）的股份

278.173

297.702

Comprehensive income attributable to HCA Healthcare, Inc.

HCA医疗保健公司的综合收入。

$3,634

$3,374

HCA Healthcare, Inc.

HCA医疗保健股份有限公司。

Condensed Consolidated Balance Sheets

简明合并资产负债表

Unaudited

未经审计

(Dollars in millions)

（百万美元）

September 30,

9月30日，

June 30,

6月30日，

December 31,

12月31日，

2023

2022

ASSETS

资产

Current assets:

流动资产：

Cash and cash equivalents

现金和现金等价物

$891

$862

$908

Accounts receivable

应收款

9,182

8,713

8,891

Inventories

库存

2,030

2,050

2,068

Other

其他

2,191

2,263

1,776

14,294

13,888

13,643

Property and equipment, at cost

财产和设备，成本

57,772

56,667

54,757

Accumulated depreciation

累计折旧

(30,655

)

(30,023

)

(29,182

)

27,117

26,644

25,575

Investments of insurance subsidiaries

保险子公司的投资

382

384

381

Investments in and advances to affiliates

投资及其分支机构

739

731

823

Goodwill and other intangible assets

善意和其他无形资产

9,778

9,641

9,653

Right-of-use operating lease assets

使用权经营租赁资产

2,079

2,110

2,065

Other

其他

200

196

298

$54,589

$53,594

$52,438

LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

责任和股东权益（赤字）

Current liabilities:

流动负债：

Accounts payable

应付款项

$4,139

$3,823

$4,239

Accrued salaries

应计工资

1,912

1,776

1,712

Other accrued expenses

其他应计费用

3,803

3,551

3,581

Long-term debt due within one year

一年内到期的长期债务

2,553

2,395

370

12,407

11,545

9,902

Long-term debt, less debt issuance costs and discounts of $341, $349 and $301

长期债务，减少债务发行成本和折扣341美元，349美元和301美元

36,793

36,537

37,714

Professional liability risks

专业责任风险

1,590

1,554

1,528

Right-of-use operating lease obligations

使用权经营租赁义务

1,776

1,806

1,752

Income taxes and other liabilities

所得税及其他负债

1,666

1,691

1,615

Stockholders' equity (deficit):

股东权益（赤字）：

Stockholders' deficit attributable to HCA Healthcare, Inc.

归因于HCA Healthcare，Inc。的股东赤字。

(2,477

)

(2,303

)

(2,767

)

Noncontrolling interests

非控制利益

2,834

2,764

2,694

357

461

(73

)

$54,589

$53,594

$52,438

HCA Healthcare, Inc.

HCA医疗保健股份有限公司。

Condensed Consolidated Statements of Cash Flows

现金流量汇总表

For the Nine Months Ended September 30, 2023 and 2022

截至2023年9月30日及2022年9月30日的9个月

Unaudited

未经审计

(Dollars in millions)

（百万美元）

2023

2022

Cash flows from operating activities:

经营活动产生的现金流量：

Net income

净收入

$4,230

$4,188

Adjustments to reconcile net income to net cash provided by operating activities:

调整净收入与经营活动提供的净现金：

Increase (decrease) in cash from operating assets and liabilities:

经营资产和负债现金增加（减少）：

Accounts receivable

应收款

(168

)

(487

)

Inventories and other assets

库存和其他资产

(274

)

Accounts payable and accrued expenses

应付款项及应计费用

211

(644

)

Depreciation and amortization

折旧和摊销

2,288

2,219

Income taxes

所得税

159

Losses on sales of facilities

设施销售损失

Losses on retirement of debt

债务退休损失

Amortization of debt issuance costs and discounts

偿还债务发行成本和折扣

Share-based compensation

股权补偿

205

258

Other

其他

166

124

Net cash provided by operating activities

经营活动提供的净现金

6,757

5,995

Cash flows from investing activities:

投资活动产生的现金流量：

Purchase of property and equipment

购买财产和设备

(3,585

)

(3,072

)

Acquisition of hospitals and health care entities

收购医院和医疗保健实体

(281

)

(176

)

Sales of hospitals and health care entities

销售医院和医疗保健实体

183

652

Change in investments

投资变化

(30

)

Other

其他

)

(10

)

Net cash used in investing activities

用于投资活动的净现金

(3,720

)

(2,596

)

Cash flows from financing activities:

融资活动产生的现金流量：

Issuances of long-term debt

长期债务的发行

3,220

5,976

Net change in revolving credit facilities

旋转信贷设施净变动

(1,420

)

(230

)

Repayment of long-term debt

偿还长期债务

(691

)

(2,774

)

Distributions to noncontrolling interests

分配给非控制利益

(497

)

(550

)

Payment of debt issuance costs

支付债务发行成本

(31

)

(53

)

Payment of dividends

支付股息

(501

)

(497

)

Repurchase of common stock

赎回普通股

(2,901

)

(5,481

)

Other

其他

(234

)

(209

)

Net cash used in financing activities

用于融资活动的净现金

(3,055

)

(3,818

)

Effect of exchange rate changes on cash and cash equivalents

汇率变动对现金和现金等价物的影响

(33

)

Change in cash and cash equivalents

现金和现金等价物的变化

(17

)

(452

)

Cash and cash equivalents at beginning of period

期初的现金和现金等价物

908

1,451

Cash and cash equivalents at end of period

期末的现金和现金等价物

$891

$999

Interest payments

利息支付

$1,460

$1,329

Income tax payments, net

所得税支付，净

$1,070

$931

HCA Healthcare, Inc.

HCA医疗保健股份有限公司。

Operating Statistics

运营统计

For the Nine Months

九个月

Third Quarter

第三季度

Ended September 30,

9月30日结束，

2023

2022

2023

2022

Operations:

操作：

Number of Hospitals

医院数量

183

182

183

182

Number of Freestanding Outpatient Surgery Centers*

独立门诊手术中心数量*

126

125

126

125

Licensed Beds at End of Period

期末持牌床位

49,279

49,179

49,279

49,179

Weighted Average Beds in Service

加权平均床位服务

41,927

42,056

41,805

41,936

Reported:

报道：

Admissions

准许进入

537,943

523,092

1,586,174

1,545,161

% Change

%改变

2.8%

2.7%

Equivalent Admissions

等效入场

958,504

917,262

2,813,873

2,679,309

% Change

%改变

4.5%

5.0%

Revenue per Equivalent Admission

每次同等入场的收入

16,915

16,322

16,939

16,697

% Change

%改变

3.6%

1.4%

Inpatient Revenue per Admission

每次入院的住院收入

18,262

17,387

17,930

17,268

% Change

%改变

5.0%

3.8%

Patient Days

患者日

2,612,439

2,602,416

7,808,905

7,855,462

% Change

%改变

0.4%

-0.6%

Equivalent Patient Days

等效患者日

4,655,252

4,565,120

13,852,997

13,621,371

% Change

%改变

2.0%

1.7%

Inpatient Surgery Cases

住院手术病例

133,521

132,470

396,428

390,311

% Change

%改变

0.8%

1.6%

Outpatient Surgery Cases

门诊手术病例

254,557

252,026

774,129

757,629

% Change

%改变

1.0%

2.2%

Emergency Room Visits

急诊室访问

2,343,514

2,278,782

6,890,388

6,559,170

% Change

%改变

2.8%

5.0%

Outpatient Revenues as a

门诊收入作为

Percentage of Patient Revenues

患者收入百分比

37.4%

36.6%

38.3%

37.6%

Average Length of Stay (days)

平均逗留时间（天）

4.856

4.975

4.923

5.084

Occupancy**

入住**

71.4%

70.8%

72.2%

72.1%

Same Facility:

同一设施：

Admissions

准许进入

536,836

519,013

1,584,488

1,533,302

% Change

%改变

3.4%

3.3%

Equivalent Admissions

等效入场

946,442

908,792

2,790,283

2,654,146

% Change

4.1%

5.1%

Revenue per Equivalent Admission

每次同等入场的收入

16,880

16,287

16,881

16,677

% Change

%改变

3.6%

1.2%

Inpatient Revenue per Admission

每次入院的住院收入

18,221

17,353

17,931

17,238

% Change

%改变

5.0%

4.0%

Inpatient Surgery Cases

住院手术病例

133,406

131,278

396,113

387,094

% Change

%改变

1.6%

2.3%

Outpatient Surgery Cases

门诊手术病例

249,723

247,580

763,622

740,808

% Change

%改变

0.9%

3.1%

Emergency Room Visits

急诊室访问

2,341,185

2,262,124

6,883,040

6,511,405

% Change

%改变

3.5%

5.7%

* Excludes freestanding endoscopy centers (22 centers at September 30, 2023 and 21 centers at September 30, 2022).

*不包括独立的内窥镜检查中心（2023年9月30日的22个中心和2022年9月30日的21个中心）。

** Reflects the rate of occupancy (patient days and observations) based on weighted average beds in service.

**根据服务中的加权平均床位反映入住率（患者天数和观察结果）。

HCA Healthcare, Inc.

HCA医疗保健股份有限公司。

Supplemental Non-GAAP Disclosures

补充非GAAP披露

Operating Results Summary

操作结果摘要

(Dollars in millions, except per share amounts)

（百万美元，不包括每股金额）

For the Nine Months

九个月

Third Quarter

第三季度

Ended September 30,

9月30日结束，

2023

2022

2023

2022

Revenues

收入

$16,213

$14,971

$47,665

$44,736

Net income attributable to HCA Healthcare, Inc.

HCA医疗保健公司的净收入。

$1,079

$1,134

$3,635

$3,562

Losses (gains) on sales of facilities (net of tax)

设施销售损失（收益）（净税）

)

Losses on retirement of debt (net of tax)

债务退休损失（税收净）

Net income attributable to HCA Healthcare, Inc., excluding losses (gains) on sales of facilities

HCA Healthcare，Inc.的净收入，不包括设施销售损失（收益）

and losses on retirement of debt (a)

和债务退休损失（a）

1,078

1,138

3,656

3,650

Depreciation and amortization

折旧和摊销

769

749

2,288

2,219

Interest expense

利息费用

483

446

1,447

1,288

Provision for income taxes

所得税的规定

354

359

1,122

1,105

Net income attributable to noncontrolling interests

归因于非控制利益的净收入

196

210

595

626

Adjusted EBITDA (a)

调整后的EBITDA（a）

$2,880

$2,902

$9,108

$8,888

Adjusted EBITDA margin (a)

调整后的EBITDA保证金（a）

17.8

19.4

19.1

19.9

Diluted earnings per share:

稀释的股份收益：

Net income attributable to HCA Healthcare, Inc.

HCA医疗保健公司的净收入。

$3.91

$13.07

$11.97

Losses (gains) on sales of facilities

设施销售损失（收益）

0.02

0.07

0.09

Losses on retirement of debt

0.20

Net income attributable to HCA Healthcare, Inc., excluding losses (gains) on sales of

HCA Healthcare，Inc.的净收入，不包括销售损失（收益）

facilities and losses on retirement of debt (a)

债务退休的设施和损失（a）

$3.91

$3.93

$13.14

$12.26

Shares used in computing diluted earnings per share (millions)

用于计算稀释的人均收益（百万）的股份

275.424

289.852

278.173

297.702

____________________

(a)

（一个）

Net income attributable to HCA Healthcare, Inc., excluding losses (gains) on sales of facilities and losses on retirement of debt, and Adjusted EBITDA should not be considered as measures of financial performance under generally accepted accounting principles ('GAAP'). We believe net income attributable to HCA Healthcare, Inc., excluding losses (gains) on sales of facilities and losses on retirement of debt, and Adjusted EBITDA are important measures that supplement discussions and analysis of our results of operations.

归因于HCA Healthcare，Inc。的净收入，不包括设施销售损失（收益）和债务退休损失，以及调整后的EBITDA不应被视为普遍接受的会计原则（'GAAP'）下的财务绩效衡量标准。我们认为可归因于HCA Healthcare，Inc。的净收入，不包括设施销售损失（收益）和债务退休损失，以及调整后的EBITDA是补充讨论和分析我们运营结果的重要措施。

We believe it is useful to investors to provide disclosures of our results of operations on the same basis used by management. Management relies upon net income attributable to HCA Healthcare, Inc., excluding losses (gains) on sales of facilities and losses on retirement of debt, and Adjusted EBITDA as the primary measures to review and assess operating performance of its health care facilities and their management teams..

我们认为，投资者在管理层使用的相同基础上披露我们的运营结果是有用的。管理层依赖于HCA Healthcare，Inc。的净收入，不包括设施销售损失（收益）和债务退休损失，调整后的EBITDA作为审查和评估其医疗机构及其管理层运营绩效的主要措施团队。。

Management and investors review both the overall performance (including net income attributable to HCA Healthcare, Inc., excluding losses (gains) on sales of facilities and losses on retirement of debt, and GAAP net income attributable to HCA Healthcare, Inc.) and operating performance (Adjusted EBITDA) of our health care facilities.

管理层和投资者审查整体业绩（包括归因于HCA Healthcare，Inc。的净收入，不包括设施销售的损失（收益）和债务退休时的损失，以及归因于HCA Healthcare，Inc。的GAAP净收入）和我们医疗机构的运营绩效（调整后的EBITDA）。

Adjusted EBITDA and the Adjusted EBITDA margin (Adjusted EBITDA divided by revenues) are utilized by management and investors to compare our current operating results with the corresponding periods during the previous year and to compare our operating results with other companies in the health care industry.

管理层和投资者利用调整后的EBITDA和调整后的EBITDA保证金（调整后的EBITDA除以收入）将我们当前的运营结果与去年的相应时期进行比较，并将我们的运营结果与医疗保健行业的其他公司进行比较。

It is reasonable to expect that losses (gains) on sales of facilities and losses on retirement of debt will occur in future periods, but the amounts recognized can vary significantly from period to period, do not directly relate to the ongoing operations of our health care facilities and complicate period comparisons of our results of operations and operations comparisons with other health care companies..

可以合理地预期，设施销售损失（收益）和债务退休损失将在未来期间发生，但确认的金额可能因期间而异，与我们医疗机构的持续运营没有直接关系，并使我们与其他医疗保健公司的运营和运营比较结果的期间比较复杂化。。

Net income attributable to HCA Healthcare, Inc., excluding losses (gains) on sales of facilities and losses on retirement of debt, and Adjusted EBITDA are not measures of financial performance under GAAP, and should not be considered as alternatives to net income attributable to HCA Healthcare, Inc.

归因于HCA Healthcare，Inc。的净收入，不包括设施销售损失（收益）和债务退休损失，以及调整后的EBITDA不是GAAP下财务绩效的衡量标准，不应被视为可归因于净收入的替代品HCA Healthcare，Inc。

as a measure of operating performance or cash flows from operating, investing and financing activities as a measure of liquidity. Because net income attributable to HCA Healthcare, Inc., excluding losses (gains) on sales of facilities and losses on retirement of debt, and Adjusted EBITDA are not measurements determined in accordance with GAAP and are susceptible to varying calculations, net income attributable to HCA Healthcare, Inc., excluding losses (gains) on sales of facilities and losses on retirement of debt, and Adjusted EBITDA, as presented, may not be comparable to other similarly titled measures presented by other companies..

衡量经营业绩或经营，投资和融资活动的现金流量，作为流动性的衡量标准。由于归因于HCA Healthcare，Inc。的净收入（不包括设施销售损失（收益）和债务退休损失）以及调整后的EBITDA不是根据GAAP确定的衡量标准，并且易于进行各种计算，因此归因于HCA的净收入医疗保健公司，不包括设施销售损失（收益）和债务退休损失，并且所提出的调整后的EBITDA可能无法与其他公司提出的其他类似标题的措施相媲美。。

HCA Healthcare, Inc.

HCA医疗保健股份有限公司。

Supplemental Non-GAAP Disclosures

补充非GAAP披露

2023 Operating Results Forecast

2023年运营结果预测

(Dollars in millions, except per share amounts)

（百万美元，不包括每股金额）

For the Year Ending

年底

December 31, 2023

2023年12月31日

Low

低

High

高

Revenues

收入

$63,250

$64,750

Net income attributable to HCA Healthcare, Inc. (a)

HCA Healthcare，Inc。的净收入（a）

$4,900

$5,255

Depreciation and amortization

折旧和摊销

3,070

3,100

Interest expense

利息费用

1,950

1,970

Provision for income taxes

所得税的规定

1,535

1,610

Net income attributable to noncontrolling interests

归因于非控制利益的净收入

845

865

Adjusted EBITDA (a) (b)

调整后的EBITDA（a）（b）

$12,300

$12,800

Diluted earnings per share:

稀释的股份收益：

Net income attributable to HCA Healthcare, Inc.

HCA医疗保健公司的净收入。

$17.70

$18.90

Shares used in computing diluted earnings per share (millions)

用于计算稀释的人均收益（百万）的股份

278.000

The Company's forecasted guidance range is based on current plans and expectations and is subject to a number of known and unknown uncertainties and risks.

公司的预测指导范围基于当前的计划和预期，并受到许多已知和未知的不确定性和风险的影响。

____________________

(a)

（一个）

The Company does not forecast the impact of items such as, but not limited to, losses (gains) on sales of facilities, losses on retirement of debt, legal claim costs (benefits) and impairments of long-lived assets because the Company does not believe that it can forecast these items with sufficient accuracy..

本公司不预测诸如但不限于设施销售损失（收益），债务退休损失，法律索赔成本（收益）和长寿资产减值等项目的影响，因为公司不相信它可以足够准确地预测这些项目。。

(b)

（b）

Adjusted EBITDA should not be considered a measure of financial performance under generally accepted accounting principles ('GAAP'). We believe Adjusted EBITDA is an important measure that supplements discussions and analysis of our results of operations. We believe it is useful to investors to provide disclosures of our results of operations on the same basis used by management.

根据普遍接受的会计准则（“GAAP”），调整后的EBITDA不应被视为衡量财务绩效的指标。我们相信调整后的EBITDA是补充讨论和分析我们运营结果的重要措施。我们认为，投资者在管理层使用的相同基础上披露我们的运营结果是有用的。

Management relies upon Adjusted EBITDA as a primary measure to review and assess operating performance of its health care facilities and their management teams..

管理层依靠调整后的EBITDA作为评估和评估其医疗机构及其管理团队运营绩效的主要措施。。

Management and investors review both the overall performance (including net income attributable to HCA Healthcare, Inc.) and operating performance (Adjusted EBITDA) of our health care facilities. Adjusted EBITDA is utilized by management and investors to compare our current operating results with the corresponding periods during the previous year and to compare our operating results with other companies in the health care industry..

管理层和投资者审查我们医疗机构的整体绩效（包括HCA Healthcare，Inc。的净收入）和运营绩效（调整后的EBITDA）。管理层和投资者利用调整后的EBITDA将我们目前的运营结果与前一年的相应时期进行比较，并将我们的运营结果与医疗保健行业的其他公司进行比较。。

Adjusted EBITDA is not a measure of financial performance under GAAP and should not be considered as an alternative to net income attributable to HCA Healthcare, Inc. as a measure of operating performance or cash flows from operating, investing and financing activities as a measure of liquidity. Because Adjusted EBITDA is not a measurement determined in accordance with GAAP and is susceptible to varying calculations, Adjusted EBITDA, as presented, may not be comparable to other similarly titled measures presented by other companies..

调整后的EBITDA不是衡量GAAP下财务绩效的指标，不应被视为HCA Healthcare，Inc。净收入的替代指标，作为衡量经营业绩或经营，投资和融资活动现金流量的流动性指标。由于调整后的EBITDA不是根据GAAP确定的衡量标准，并且容易受到不同计算的影响，因此调整后的EBITDA可能无法与其他公司提出的其他类似标题的衡量标准相媲美。。

全球产业链接平台

重庆市渝北区金星科技大厦A区5楼512室

联系电话：023-67139735（重庆）

关于我们

产品服务